-
Liaoning Chengda Biotech to See Actual Controller Change of Controlling Shareholder
•
China’s Liaoning Chengda Biotechnology Co., Ltd (SHA: 688739) announced a proposed change in the actual controller of its controlling shareholder Liaoning Chengda Co., Ltd. The actual controller will change from the State-owned Assets Supervision and Administration Commission of Liaoning Provincial Government to no actual controller. Control Change and Its ImplicationsWith…
-
Liaoning Chengda’s ACYW135 Meningococcal Vaccine Receives NMPA Clearance
•
China’s Liaoning Chengda Biotechnology Co., Ltd (SHA: 688739) has announced that it has received clinical clearance from the National Medical Products Administration (NMPA) for its ACYW135 meningococcal polysaccharide conjugate vaccine. The vaccine is designed to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis of groups A, C, Y, and W135.…
